{"id":30010,"date":"2026-11-19T14:31:27","date_gmt":"2026-11-19T21:31:27","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=30010"},"modified":"2026-11-19T14:42:18","modified_gmt":"2026-11-19T21:42:18","slug":"usos-dosis-efectos-secundarios-y-advertencias-de-eltrombopag-promacta","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/","title":{"rendered":"Eltrombopag ( Promacta): Usos, dosis, efectos secundarios y advertencias"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Eltrombopag (nombre comercial Promacta) es un medicamento oral recetado para aumentar el recuento de plaquetas en personas con ciertos trastornos sangu\u00edneos, incluyendo: <a href=\"https:\/\/ameripharmaspecialty.com\/es\/otras-afecciones-de-salud\/purpura-trombocitopenica-idiopatica-pti\/\">trombocitopenia inmune cr\u00f3nica (PTI)<\/a>. Las plaquetas son fragmentos de c\u00e9lulas sangu\u00edneas que ayudan a formar co\u00e1gulos y a detener el sangrado.&nbsp;&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-c0223dfdc21bb51ec54ab622678c327c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfCalifica usted para el copago $0?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tDesc\u00fabrelo ahora\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">En 2008, eltrombopag ( Promacta) recibi\u00f3 <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/022291lbl.pdf\">aprobaci\u00f3n<\/a> La Administraci\u00f3n de Alimentos y Medicamentos (FDA) aprob\u00f3 este medicamento para tratar a ciertos adultos con trombocitopenia inmune cr\u00f3nica (PTI). Posteriormente, la FDA ampli\u00f3 su uso aprobado para incluir otras afecciones asociadas con recuentos bajos de c\u00e9lulas sangu\u00edneas. Los efectos secundarios comunes de este medicamento pueden incluir n\u00e1useas, dolor de cabeza, diarrea, infecciones del tracto urinario, infecciones de las v\u00edas respiratorias superiores y fiebre.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este art\u00edculo trata sobre eltrombopag ( Promacta), incluyendo sus usos, presentaciones disponibles, administraci\u00f3n, dosis recomendadas y posibles efectos secundarios.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_90 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Eltrombopag_Promacta_FDA-Approved_Uses\" >Eltrombopag ( Promacta): Usos aprobados por la FDA<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Mechanism_of_Action_MOA\" >Mecanismo de acci\u00f3n (MOA)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Drug_Form\" >Forma del f\u00e1rmaco<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Recommended_Dosage\" >Dosis recomendada<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Dosage_for_Persistent_or_Chronic_ITP\" >Dosis para la PTI persistente o cr\u00f3nica<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Dosage_for_Chronic_Hepatitis_C-associated_Thrombocytopenia\" >Dosificaci\u00f3n para la trombocitopenia cr\u00f3nica asociada a la hepatitis C<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#First-line_Severe_Aplastic_Anemia\" >Anemia apl\u00e1sica grave de primera l\u00ednea<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Refractory_Severe_Aplastic_Anemia\" >Anemia apl\u00e1sica grave refractaria<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Eltrombopag_Promacta_When_and_How_it_Should_be_Taken\" >Eltrombopag ( Promacta): Cu\u00e1ndo y c\u00f3mo debe tomarse<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Possible_Side_Effects\" >Posibles efectos secundarios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Safety_Measures\" >Medidas de seguridad<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#Eltrombopag_Promacta_Cost\" >Eltrombopag ( Promacta): Costo<\/a><\/li><\/ul><\/nav><\/div>\n<h2 id=\"h-eltrombopag-promacta-fda-approved-uses\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Eltrombopag_Promacta_FDA-Approved_Uses\"><\/span><strong>Eltrombopag ( Promacta): Usos aprobados por la FDA<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La FDA ha aprobado eltrombopag ( Promacta) para varias afecciones asociadas con recuentos bajos de plaquetas o c\u00e9lulas sangu\u00edneas, incluida la trombocitopenia inmune persistente o cr\u00f3nica (PTI) en adultos y ni\u00f1os de 1 a\u00f1o o m\u00e1s. Sus usos aprobados incluyen:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Para tratar a adultos y ni\u00f1os de 1 a\u00f1o de edad o mayores con PTI persistente o cr\u00f3nica que no han respondido adecuadamente a los corticosteroides, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/guia-para-el-tratamiento-con-ivig-para-la-pti\/\">inmunoglobulinas<\/a>, o esplenectom\u00eda. Debe utilizarse \u00fanicamente en pacientes cuyo estado y grado de trombocitopenia aumenten su riesgo de hemorragia.&nbsp;<\/li>\n\n\n\n<li>Para tratar la disminuci\u00f3n del recuento de plaquetas en pacientes con hepatitis C cr\u00f3nica que necesitan iniciar y mantener una terapia basada en interfer\u00f3n.&nbsp;<\/li>\n\n\n\n<li>Como tratamiento de primera l\u00ednea en combinaci\u00f3n con la terapia inmunosupresora est\u00e1ndar para adultos y ni\u00f1os de 2 a\u00f1os o m\u00e1s con <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/aplastic-anemia\/symptoms-causes\/syc-20355015\">anemia apl\u00e1sica grave<\/a> (SAA).&nbsp;<\/li>\n\n\n\n<li>Para tratar a pacientes con anemia apl\u00e1sica grave (AAG) que no han respondido adecuadamente a la terapia inmunosupresora.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">No se recomienda el uso de Promacta (eltrombopag) para tratar a pacientes con s\u00edndromes mielodispl\u00e1sicos (SMD).&nbsp;<\/p>\n\n\n\n<h2 id=\"h-mechanism-of-action-moa\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanism_of_Action_MOA\"><\/span><strong>Mecanismo de acci\u00f3n (MOA)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Eltrombopag ( Promacta) pertenece a la clase de medicamentos llamados agonistas del receptor de la trombopoyetina (TPO). Activa los receptores de la trombopoyetina en la m\u00e9dula \u00f3sea, estimulando la producci\u00f3n de plaquetas.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Al aumentar la producci\u00f3n de plaquetas, eltrombopag ( Promacta) puede ayudar a reducir el riesgo de hemorragia en pacientes con recuentos bajos de plaquetas. En pacientes con anemia apl\u00e1sica grave, tambi\u00e9n puede mejorar los recuentos de gl\u00f3bulos rojos y blancos.&nbsp;<\/p>\n\n\n\n<h2 id=\"h-drug-form\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Drug_Form\"><\/span><strong>Forma del f\u00e1rmaco<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Promacta (eltrombopag) se presenta en dos formatos. Uno es un comprimido oral disponible en dosis de 12,5 mg, 25 mg, 50 mg y 75 mg. El otro es un sobre de polvo disponible en dosis de 12,5 mg y 25 mg que se mezcla con agua para crear una suspensi\u00f3n oral (l\u00edquido).&nbsp;<\/p>\n\n\n\n<h2 id=\"h-recommended-dosage\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recommended_Dosage\"><\/span><strong>Dosis recomendada<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La dosis de eltrombopag ( Promacta) var\u00eda seg\u00fan la afecci\u00f3n que se est\u00e9 tratando, la edad del paciente, la funci\u00f3n hep\u00e1tica y la respuesta al tratamiento. A continuaci\u00f3n, se indican las dosis recomendadas por la FDA para pacientes adultos y pedi\u00e1tricos.<\/p>\n\n\n\n<h3 id=\"h-dosage-for-persistent-or-chronic-itp\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_for_Persistent_or_Chronic_ITP\"><\/span><strong>Dosis para la PTI persistente o cr\u00f3nica<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">La dosis inicial recomendada para la mayor\u00eda de los adultos y ni\u00f1os de 6 a\u00f1os o m\u00e1s con PTI persistente o cr\u00f3nica es de 50 mg por v\u00eda oral una vez al d\u00eda. Para ni\u00f1os de 1 a 5 a\u00f1os, la dosis inicial recomendada es de 25 mg una vez al d\u00eda.&nbsp;<\/p>\n\n\n\n<h3 id=\"h-dosage-for-chronic-hepatitis-c-associated-thrombocytopenia\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_for_Chronic_Hepatitis_C-associated_Thrombocytopenia\"><\/span><strong>Dosificaci\u00f3n para la trombocitopenia cr\u00f3nica asociada a la hepatitis C<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Para pacientes con enfermedad cr\u00f3nica <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5333732\/\">trombocitopenia asociada a la hepatitis C<\/a>, La dosis inicial recomendada de Promacta es de 25 mg por v\u00eda oral una vez al d\u00eda. La dosis puede ajustarse seg\u00fan el recuento de plaquetas y la respuesta al tratamiento.&nbsp;<\/p>\n\n\n\n<h3 id=\"h-first-line-severe-aplastic-anemia\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"First-line_Severe_Aplastic_Anemia\"><\/span><strong>Anemia apl\u00e1sica grave de primera l\u00ednea<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">La dosis de Promacta en combinaci\u00f3n con la terapia inmunosupresora est\u00e1ndar para el tratamiento de la anemia apl\u00e1sica grave es la siguiente:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Para pacientes pedi\u00e1tricos de 2 a 5 a\u00f1os: Promacta por v\u00eda oral una vez al d\u00eda a una dosis de 2,5 mg\/kg.<\/li>\n\n\n\n<li>Para pacientes pedi\u00e1tricos de 6 a 11 a\u00f1os: un comprimido de 75 mg una vez al d\u00eda.<\/li>\n\n\n\n<li>Para pacientes de 12 a\u00f1os o m\u00e1s: 150 mg por v\u00eda oral una vez al d\u00eda, simult\u00e1neamente con la terapia inmunosupresora est\u00e1ndar.&nbsp;<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-26430d8fa1f3d9a68692f8bb740f87fe\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">M\u00e1s informaci\u00f3n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 id=\"h-refractory-severe-aplastic-anemia\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Refractory_Severe_Aplastic_Anemia\"><\/span><strong>Anemia apl\u00e1sica grave refractaria<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">La dosis inicial recomendada para pacientes con anemia apl\u00e1sica grave refractaria es de 50 mg por v\u00eda oral una vez al d\u00eda. La dosis puede ajustarse seg\u00fan el recuento sangu\u00edneo y la respuesta al tratamiento.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los pacientes con problemas hep\u00e1ticos o de ascendencia asi\u00e1tica oriental o del sudeste asi\u00e1tico podr\u00edan requerir una dosis inicial m\u00e1s baja de Promacta. Sin embargo, los ajustes de dosis var\u00edan seg\u00fan la afecci\u00f3n que se est\u00e9 tratando. Su m\u00e9dico determinar\u00e1 la dosis adecuada y la ajustar\u00e1 seg\u00fan su respuesta al tratamiento.&nbsp;<\/p>\n\n\n\n<h2 id=\"h-eltrombopag-promacta-when-and-how-it-should-be-taken\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Eltrombopag_Promacta_When_and_How_it_Should_be_Taken\"><\/span><strong>Eltrombopag ( Promacta): Cu\u00e1ndo y c\u00f3mo debe tomarse<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Eltrombopag debe tomarse seg\u00fan lo recetado por su m\u00e9dico. Debe tomar este medicamento sin alimentos o con una comida baja en calcio (50 mg o menos). Adem\u00e1s, tome su dosis al menos 2 horas antes o 4 horas despu\u00e9s de consumir alimentos ricos en calcio, productos l\u00e1cteos, anti\u00e1cidos o suplementos minerales que contengan calcio, hierro, magnesio, aluminio o zinc.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Comprimidos de eltrombopag ( Promacta)<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Trague los comprimidos de Promacta enteros. No los parta, mastique ni triture, y no los mezcle con alimentos ni l\u00edquidos.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Suspensi\u00f3n oral de eltrombopag ( Promacta)<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Si su m\u00e9dico le receta Promacta suspensi\u00f3n oral (l\u00edquida), aseg\u00farese de comprender c\u00f3mo preparar y medir la dosis.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Siga siempre las instrucciones de preparaci\u00f3n que acompa\u00f1an al medicamento y utilice el frasco mezclador y la jeringa dosificadora oral suministrados. Los sobres de polvo de Promacta deben mezclarse \u00fanicamente con agua fr\u00eda o templada. No utilice agua caliente para preparar la suspensi\u00f3n oral.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tome la dosis de suspensi\u00f3n oral inmediatamente despu\u00e9s de mezclarla con agua. Si no la toma en 30 minutos, deber\u00e1 preparar una nueva dosis. Deseche la mezcla sobrante en la basura.&nbsp;<\/p>\n\n\n\n<h2 id=\"h-possible-side-effects\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Possible_Side_Effects\"><\/span><strong>Posibles efectos secundarios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"236\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects.jpg\" alt=\"Mujer que sufre de fiebre, un efecto secundario de tomar eltrombopag ( Promacta). \" class=\"wp-image-30015\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects-300x169.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects-18x10.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects-86x48.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects-167x94.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects-280x157.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/eltrombopag-side-effects-370x208.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Los efectos secundarios m\u00e1s comunes de Promacta var\u00edan seg\u00fan la afecci\u00f3n que se est\u00e9 tratando y pueden incluir:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Niveles bajos de gl\u00f3bulos rojos (<a href=\"https:\/\/www.webmd.com\/a-to-z-guides\/understanding-anemia-basics\">anemia<\/a>)<\/li>\n\n\n\n<li>N\u00e1useas<\/li>\n\n\n\n<li>Fiebre<\/li>\n\n\n\n<li>Anormal&nbsp;<a href=\"https:\/\/www.webmd.com\/fatty-liver-disease\/liver-function-test-lft\">pruebas de funci\u00f3n hep\u00e1tica<\/a><\/li>\n\n\n\n<li>Tos<\/li>\n\n\n\n<li>Sentirse cansado<\/li>\n\n\n\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>Erupci\u00f3n<\/li>\n\n\n\n<li>decoloraci\u00f3n de la piel (hiperpigmentaci\u00f3n)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Los pacientes que toman Promacta (eltrombopag) tambi\u00e9n pueden experimentar efectos secundarios graves durante el tratamiento, tales como:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reacciones al\u00e9rgicas graves<\/li>\n\n\n\n<li>Da\u00f1o hep\u00e1tico (hepatotoxicidad)<\/li>\n\n\n\n<li>Recuento elevado de plaquetas y mayor riesgo de co\u00e1gulos sangu\u00edneos.<\/li>\n\n\n\n<li>Empeoramiento de la funci\u00f3n hep\u00e1tica en pacientes con hepatitis C cr\u00f3nica que reciben Promacta con interfer\u00f3n y ribavirina.<\/li>\n\n\n\n<li>Mayor riesgo de cataratas o empeoramiento de la progresi\u00f3n del s\u00edndrome mielodispl\u00e1sico (SMD) a leucemia mieloide aguda (LMA).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Promacta incluye una advertencia de la FDA sobre problemas hep\u00e1ticos graves. Los pacientes con hepatitis C cr\u00f3nica que toman Promacta junto con interfer\u00f3n y ribavirina pueden experimentar un empeoramiento de la funci\u00f3n hep\u00e1tica. Promacta tambi\u00e9n puede causar da\u00f1o hep\u00e1tico grave. Su m\u00e9dico controlar\u00e1 su funci\u00f3n hep\u00e1tica antes y durante el tratamiento.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Informe a su m\u00e9dico si experimenta efectos secundarios que persisten o empeoran. Busque atenci\u00f3n m\u00e9dica inmediata si presenta s\u00edntomas de una reacci\u00f3n al\u00e9rgica grave, un co\u00e1gulo de sangre o una lesi\u00f3n hep\u00e1tica.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-c12575373eedac32a830fadc59a6872c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 id=\"h-safety-measures\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Safety_Measures\"><\/span><strong>Medidas de seguridad<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Para determinar si eltrombopag ( Promacta) es seguro para usted o su hijo, informe a su proveedor de atenci\u00f3n m\u00e9dica sobre su historial m\u00e9dico, los medicamentos que toma actualmente y cualquier afecci\u00f3n m\u00e9dica, incluyendo si:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tiene problemas de h\u00edgado<\/li>\n\n\n\n<li>Tener <a href=\"https:\/\/www.mdanderson.org\/cancer-types\/myelodysplastic-syndrome.html\">s\u00edndrome mielodispl\u00e1sico<\/a> (SMD), ya que Promacta no est\u00e1 aprobado para tratar esta afecci\u00f3n y puede aumentar el riesgo de progresi\u00f3n a leucemia mieloide aguda (LMA).&nbsp;<\/li>\n\n\n\n<li>Tiene o ha tenido un co\u00e1gulo de sangre&nbsp;<\/li>\n\n\n\n<li>Tiene antecedentes de cataratas.&nbsp;<\/li>\n\n\n\n<li>\u00bfTe han operado para extirparte el bazo (esplenectom\u00eda)?<\/li>\n\n\n\n<li>Tengo problemas de sangrado<\/li>\n\n\n\n<li>Si est\u00e1 embarazada o planea quedar embarazada, tenga en cuenta que Promacta puede da\u00f1ar al feto.<\/li>\n\n\n\n<li>Si est\u00e1 amamantando o planea amamantar, tenga en cuenta que no se recomienda la lactancia materna durante el tratamiento con Promacta ni durante al menos 7 d\u00edas despu\u00e9s de la \u00faltima dosis.<\/li>\n\n\n\n<li>\u00bfEst\u00e1 tomando alg\u00fan medicamento con o sin receta, incluyendo estatinas, anti\u00e1cidos, suplementos minerales, multivitaminas o productos a base de hierbas? Algunos de estos productos pueden interactuar con Promacta.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Su m\u00e9dico tambi\u00e9n controlar\u00e1 el recuento de plaquetas y la funci\u00f3n hep\u00e1tica durante el tratamiento. Los an\u00e1lisis de sangre peri\u00f3dicos ayudan a determinar si el medicamento est\u00e1 funcionando y si es necesario ajustar la dosis.&nbsp;<\/p>\n\n\n\n<h2 id=\"h-eltrombopag-promacta-cost\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Eltrombopag_Promacta_Cost\"><\/span><strong>Eltrombopag ( Promacta): Costo<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El eltrombopag ( Promacta) puede ser costoso, aunque ahora existen versiones gen\u00e9ricas de las tabletas de eltrombopag que pueden costar menos que el medicamento de marca. Los pacientes deben consultar con su farmacia o compa\u00f1\u00eda de seguros para conocer los precios actuales.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El costo que usted deber\u00e1 pagar de su bolsillo tambi\u00e9n puede variar dependiendo de los beneficios de su seguro, la dosis y la duraci\u00f3n del tratamiento. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/asistencia-financiera\/\">Cont\u00e1ctanos<\/a> si est\u00e1 interesado en asistencia financiera o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/eltrombopag-copay-assistance\/\">Asistencia para el copago de eltrombopag ( Promacta)<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Eltrombopag (nombre comercial Promacta) es un medicamento oral que se receta para aumentar el recuento de plaquetas en personas con ciertos trastornos sangu\u00edneos, incluida la trombocitopenia inmune cr\u00f3nica (PTI). Las plaquetas son fragmentos de c\u00e9lulas sangu\u00edneas que ayudan a formar co\u00e1gulos y detener el sangrado.\u00a0<\/p>","protected":false},"author":25,"featured_media":30012,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[31],"class_list":["post-30010","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-mark-alfonso"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.9 (Yoast SEO v28.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about eltrombopag (Promacta), including its uses for low platelet counts, recommended dosages, side effects, warnings, and safety precautions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/otras-afecciones-de-salud\/usos-dosis-efectos-secundarios-y-advertencias-de-eltrombopag-promacta\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings\" \/>\n<meta property=\"og:description\" content=\"Learn about eltrombopag (Promacta), including its uses for low platelet counts, recommended dosages, side effects, warnings, and safety precautions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/otras-afecciones-de-salud\/usos-dosis-efectos-secundarios-y-advertencias-de-eltrombopag-promacta\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-19T21:31:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-19T21:42:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/59625de200ab1e1ea9ba9addfe1569be\"},\"headline\":\"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings\",\"datePublished\":\"2026-11-19T21:31:27+00:00\",\"dateModified\":\"2026-11-19T21:42:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/\"},\"wordCount\":1279,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/blood-cells-platelets.jpg\",\"keywords\":[\"Dr. Mark Alfonso\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/\",\"name\":\"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/blood-cells-platelets.jpg\",\"datePublished\":\"2026-11-19T21:31:27+00:00\",\"dateModified\":\"2026-11-19T21:42:18+00:00\",\"description\":\"Learn about eltrombopag (Promacta), including its uses for low platelet counts, recommended dosages, side effects, warnings, and safety precautions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/blood-cells-platelets.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/blood-cells-platelets.jpg\",\"width\":1280,\"height\":853},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/other-health-conditions\\\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/59625de200ab1e1ea9ba9addfe1569be\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eltrombopag ( Promacta): Usos, dosis, efectos secundarios y advertencias - AmeriPharma \u00ae Specialty Care","description":"Inf\u00f3rmese sobre eltrombopag ( Promacta), incluyendo sus usos para recuentos bajos de plaquetas, dosis recomendadas, efectos secundarios, advertencias y precauciones de seguridad.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/otras-afecciones-de-salud\/usos-dosis-efectos-secundarios-y-advertencias-de-eltrombopag-promacta\/","og_locale":"es_MX","og_type":"article","og_title":"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings","og_description":"Learn about eltrombopag (Promacta), including its uses for low platelet counts, recommended dosages, side effects, warnings, and safety precautions.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/otras-afecciones-de-salud\/usos-dosis-efectos-secundarios-y-advertencias-de-eltrombopag-promacta\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2026-11-19T21:31:27+00:00","article_modified_time":"2026-11-19T21:42:18+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/59625de200ab1e1ea9ba9addfe1569be"},"headline":"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings","datePublished":"2026-11-19T21:31:27+00:00","dateModified":"2026-11-19T21:42:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/"},"wordCount":1279,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg","keywords":["Dr. Mark Alfonso"],"articleSection":["Other Health Conditions"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/","url":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/","name":"Eltrombopag ( Promacta): Usos, dosis, efectos secundarios y advertencias - AmeriPharma \u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg","datePublished":"2026-11-19T21:31:27+00:00","dateModified":"2026-11-19T21:42:18+00:00","description":"Inf\u00f3rmese sobre eltrombopag ( Promacta), incluyendo sus usos para recuentos bajos de plaquetas, dosis recomendadas, efectos secundarios, advertencias y precauciones de seguridad.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg","width":1280,"height":853},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/eltrombopag-promacta-uses-dosage-side-effects-and-warnings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Eltrombopag (Promacta): Uses, Dosage, Side Effects, and Warnings"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/59625de200ab1e1ea9ba9addfe1569be","name":"Dr. Mark Alfonso, PharmD, BCMTMS","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"El Dr. Mark Alfonso, doctor en farmacia, naci\u00f3 y creci\u00f3 en Pueblo, Colorado. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Colorado, en el Campus M\u00e9dico Anschutz, en 2010. Obtuvo su certificaci\u00f3n en gesti\u00f3n de terapias farmacol\u00f3gicas en 2022. Lo m\u00e1s gratificante de su trabajo es ayudar a responder las preguntas e inquietudes de los pacientes. Sus \u00e1reas de especializaci\u00f3n son la farmacia comunitaria y la gesti\u00f3n de terapias farmacol\u00f3gicas. En su tiempo libre, disfruta de la lectura y correr.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Eltrombopag (brand name Promacta) is an oral medication prescribed to increase platelet counts in people with certain blood disorders, including chronic immune thrombocytopenia (ITP). Platelets are blood cell fragments that help form clots and stop bleeding.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/11\/blood-cells-platelets.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"Eltrombopag (brand name Promacta) is an oral medication prescribed to increase platelet counts in people with certain blood disorders, including chronic immune thrombocytopenia (ITP). Platelets are blood cell fragments that help form clots and stop bleeding.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/30010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=30010"}],"version-history":[{"count":6,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/30010\/revisions"}],"predecessor-version":[{"id":30028,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/30010\/revisions\/30028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/30012"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=30010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=30010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=30010"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}